Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcela V Maus

Showing results (11-20 of 235) with videos related to

Pageof 24
Sort By:
Journal for Immunotherapy of Cancer|April 22, 2017
The Why, what, and How of the New FACT standards for immune effector cellsMarcela V Maus, Sarah Nikiforow
Nature Medicine|August 30, 2024
Tracking non-relapse mortality after CAR T cell therapyViktoria Blumenberg, Marcela V Maus
Nature Medicine|March 27, 2023
Linking the microbiome to CAR-T cell responsesZachariah DeFilipp, Marcela V Maus
Nature Biotechnology|October 26, 2023
Expanding access to CAR T cell therapies through local manufacturingMagdi Elsallab, Marcela V Maus
Immunity|October 11, 2023
Synthetic manipulation of the cancer-immunity cycle: CAR-T cell therapyNathan Singh, Marcela V Maus
Molecular Therapy. Oncology|June 8, 2026
Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinationsGiulia Escobar, Marcela V Maus
Cancer Cell|February 13, 2020
Unraveling the Signaling Balance of Activation and Exhaustion of CAR T CellsIrene Scarfò, Marcela V Maus
Current Opinion in Pharmacology|July 1, 2021
New CARs on and off the road: challenges and new developments in CAR-T cell therapyMarc Wehrli, Marcela V Maus
The Journal of Experimental Medicine|May 7, 2026
When tumor contact reshapes CAR-T cellsSangwoo Park, Marcela V Maus
Frontiers in Immunology|November 24, 2018
Making CAR T Cells a Solid Option for Solid TumorsAndrea Schmidts, Marcela V Maus
Pageof 24

Showing results (11-20 of 235) with videos related to

Sort By:
Pageof 24
Journal for Immunotherapy of Cancer|April 22, 2017
The Why, what, and How of the New FACT standards for immune effector cellsMarcela V Maus, Sarah Nikiforow
Nature Medicine|August 30, 2024
Tracking non-relapse mortality after CAR T cell therapyViktoria Blumenberg, Marcela V Maus
Nature Medicine|March 27, 2023
Linking the microbiome to CAR-T cell responsesZachariah DeFilipp, Marcela V Maus
Nature Biotechnology|October 26, 2023
Expanding access to CAR T cell therapies through local manufacturingMagdi Elsallab, Marcela V Maus
Immunity|October 11, 2023
Synthetic manipulation of the cancer-immunity cycle: CAR-T cell therapyNathan Singh, Marcela V Maus
Molecular Therapy. Oncology|June 8, 2026
Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinationsGiulia Escobar, Marcela V Maus
Cancer Cell|February 13, 2020
Unraveling the Signaling Balance of Activation and Exhaustion of CAR T CellsIrene Scarfò, Marcela V Maus
Current Opinion in Pharmacology|July 1, 2021
New CARs on and off the road: challenges and new developments in CAR-T cell therapyMarc Wehrli, Marcela V Maus
The Journal of Experimental Medicine|May 7, 2026
When tumor contact reshapes CAR-T cellsSangwoo Park, Marcela V Maus
Frontiers in Immunology|November 24, 2018
Making CAR T Cells a Solid Option for Solid TumorsAndrea Schmidts, Marcela V Maus
Pageof 24